DalsnaFinance › Analyst accuracy › All targets
Every price target we have verified from published news, newest first: 32 targets from Oppenheimer. Each one shows the article it came from and links to its full entry, and is judged on the close on the date it comes due. “At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target.
Showing targets from Oppenheimer only. All targets Oppenheimer’s record →
Oppenheimer lowered its price target on CorMedix Inc. shares (NASDAQ:CRMD) to $13 from $15 while maintaining an Outperform rating on the stock.
On Nov. 9, he upgraded AMD to "Outperform" and assigned a bullish $600 price target.
Oppenheimer reiterated an Outperform rating and $25.00 price target on Climb Bio (NASDAQ:CLYM) shares.
Oppenheimer reiterated an Outperform rating and $7.00 price target on Serve Robotics (NASDAQ:SERV).
Oppenheimer reiterated an Outperform rating and $300.00 price target on Autodesk stock
Oppenheimer upgraded Incyte (NASDAQ:INCY) to Outperform from Perform and raised its price target to $144 from $120.
Oppenheimer reiterated an Outperform rating and $60.00 price target on UroGen Pharma
Oppenheimer initiated coverage on PolyPid Ltd. with an outperform rating and a price target of $10.00.
to $16 from $35 while maintaining an Outperform rating
Oppenheimer lowered its price target on Louisiana-Pacific Corp to $104 from $107 while maintaining an Outperform rating.
Oppenheimer raised its price target on Amgen Inc. (NASDAQ:AMGN) to $480 from $450 while maintaining an Outperform rating.
Oppenheimer reiterated an Outperform rating on Almonty Industries Inc. (NASDAQ:ALM) with a $19.00 price target
Oppenheimer reiterated an Outperform rating on Agilysys Inc ... with a $118.00 price target
Oppenheimer reiterated an Outperform rating and $47.00 price target on Unity Software.
Oppenheimer has reduced its price target to $17 from $95, also maintaining an Outperform rating post-spin-off.
Oppenheimer initiates Cavco Industries stock with outperform rating
Salesforce stock rating reaffirmed by Oppenheimer after customer survey
Oppenheimer raised its price target on Microsoft to $570 from $515 on Tuesday, keeping its Outperform rating in place.
Oppenheimer lowered its price target on AutoZone shares ([NYSE:AZO]) to $3,500 from $4,300 while maintaining an Outperform rating, the firm said Wednesday.
Oppenheimer reiterated an Outperform rating on Oracle Corp. with a $275.00 price target.
Oppenheimer Maintains Broadcom(AVGO.US) With Buy Rating, Announces Target Price $535
Oppenheimer cut its price target to $380 from $406 while maintaining its Outperform rating
Oppenheimer raised its price target on Workday shares to $220 from $165 on Monday while maintaining an Outperform rating ahead of the company's second-quarter results scheduled for Thursday.
$500.00 price target on the stock.
Amgen had its price target raised by Oppenheimer Holdings, Inc. from $400.00 to $450.00.
Oppenheimer raised its price target on Incyte Corp. to $120 from $107 while maintaining a Perform rating on Monday.
Oppenheimer reiterated an Outperform rating and $230.00 price target on Corning shares.
MSFT Reiterated by Oppenheimer -- Price Target Maintained at $51
Oppenheimer raised its price target on GE Vernova shares (NYSE:GEV) to $1,338 from $1,303 while maintaining an Outperform rating on Tuesday.
Oppenheimer reiterates an Outperform rating and $225.00 price target on Veeva Systems stock
UNH Maintained by Oppenheimer -- Price Target Raised to $500
Investing.com - Oppenheimer lowered its price target on Netflix Inc. (NASDAQ:NFLX) to $85 from $100 while maintaining an Outperform rating on the stock.
Retracted targets, ones we found we had misreported, are not listed here and count toward nothing; each firm's row on the analyst accuracy page lists its own under "Retracted". These are facts about what each firm published, not recommendations from Dalsna Finance.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.